Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBT Margin: 2017-2020

Historic EBT Margin for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to -18,325.64%.

  • Cogent Biosciences' EBT Margin fell 1714868.00% to -18,325.64% in Q3 2020 from the same period last year, while for Sep 2020 it was -295.22%, marking a year-over-year increase of 9338.00%. This contributed to the annual value of -1,042.50% for FY2020, which is 90066.00% down from last year.
  • Per Cogent Biosciences' latest filing, its EBT Margin stood at -18,325.64% for Q3 2020, which was down 1,207.56% from -1,401.52% recorded in Q2 2020.
  • Cogent Biosciences' 5-year EBT Margin high stood at 15.05% for Q4 2019, and its period low was -18,325.64% during Q3 2020.
  • Its 3-year average for EBT Margin is -2,116.33%, with a median of -382.93% in 2019.
  • Examining YoY changes over the last 5 years, Cogent Biosciences' EBT Margin showed a top increase of 29,626bps in 2020 and a maximum decrease of 1,714,868bps in 2020.
  • Cogent Biosciences' EBT Margin (Quarterly) stood at -319.41% in 2017, then spiked by 9,349bps to -225.91% in 2018, then surged by 24,096bps to 15.05% in 2019, then tumbled by 1,714,868bps to -18,325.64% in 2020.
  • Its EBT Margin was -18,325.64% in Q3 2020, compared to -1,401.52% in Q2 2020 and -86.67% in Q1 2020.